Randomized comparison of ranitidine bismuth citrate (RBC)-based triple therapies for H-pylori (HP).

被引：0
|
作者：
Laine, L [1 ]
Estrada, R [1 ]
Trujillo, M [1 ]
Emami, S [1 ]
机构：
[1] UNIV SO CALIF, SCH MED, LOS ANGELES, CA 90089 USA
来源：
GASTROENTEROLOGY | 1997年 / 112卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A192 / A192
页数：1
相关论文
共 50 条
  • [41] A comparison of ranitidine bismuth citrate-clarithromycin (RBC-C) dual therapy vs. omeprazole, clarithromycin, amoxycillin (OCA) triple therapy given for 7 days in the treatment of H-pylori infection
    van Zanten, SJOV
    Chiba, N
    Barkun, AN
    Fallone, CA
    Farley, A
    Cockeram, A
    Dallaire, C
    Simms, L
    Nicholls, B
    [J]. GASTROENTEROLOGY, 2001, 120 (05) : A586 - A586
  • [42] Comparison between two amoxicillin/tetracycline based triple therapies for H-pylori infection
    Perri, F
    Clemente, R
    Festa, V
    Quitadamo, M
    Niro, GA
    Ricciardi, R
    Andriulli, A
    [J]. GUT, 1998, 43 : A90 - A90
  • [43] Treatment of Helicobacter pylori infection -: Triple regimen based on ranitidine bismuth citrate could be solution
    Savarino, V
    Neri, M
    Vigneri, S
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7248): : 1541 - 1541
  • [44] Randomized comparison of amoxicillin/tetracycline based triple therapies for H-pylori.
    Perri, F
    Clemente, R
    Festa, V
    Quitadamo, M
    Andriulli, A
    [J]. GASTROENTEROLOGY, 1998, 114 (04) : A256 - A257
  • [45] Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy
    Rinaldi, V
    Zullo, A
    De Francesco, V
    Hassan, C
    Winn, S
    Stoppino, V
    Faleo, D
    Attili, AF
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 (02) : 163 - 168
  • [46] Effectiveness of a ranitidine bismuth citrate triple therapy for treating Helicobacter pylori.
    Smoot, DT
    Hinds, T
    Ashktorab, H
    Jagtap, J
    Kim, KS
    [J]. GASTROENTEROLOGY, 1998, 114 (04) : A290 - A290
  • [47] Ranitidine bismuth citrate, azithromycin and amoxicillin in comparison with omeprazole, azithromycin and amoxicillin in the therapy of H-pylori positive patients with peptic ulcer disease
    Katicic, M
    Pavic-Sladoljev, D
    Prskalo, M
    Sabaric, B
    Skurla, B
    Ticak, M
    [J]. GUT, 2001, 49 : A91 - A92
  • [48] Levofloxacin-vs. ranitidine bismuth citrate-containing therapy after H-pylori treatment failure
    Gisbert, Javier P.
    Gisbert, Jose Luis
    Marcos, Santiago
    Moreno-Otero, Ricardo
    Pajares, Jose Maria
    [J]. HELICOBACTER, 2007, 12 (01) : 68 - 73
  • [49] Triple regimens using lansoprazole or ranitidine bismuth citrate for Helicobacter pylori eradication
    Spadaccini, A
    De Fanis, C
    Sciampa, G
    Russo, L
    Silla, M
    Pantaleone, U
    Di Virgilio, M
    Pizzicanella, G
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 (10) : 997 - 1001
  • [50] Synergism study of ranitidine bismuth citrate and metronidazole against metronidazole resistant H-pylori clinical isolates.
    LopezBrea, M
    Domingo, D
    Sanchez, I
    Alarcon, T
    [J]. GASTROENTEROLOGY, 1997, 112 (04) : A201 - A201
12345